Nordic AML Meeting 2023

Radisson BLU Royal Hotel Bergen, Norway

The Nordic AML meeting is a unique opportunity to learn about the latest clinical and scientific developments in the field of AML. The meeting will feature great keynote speakers from both Nordic countries and around the world. We will have an exciting program that covers a broad range of topics, including novel therapies, clinical trials, genetics, and molecular biology.
We are also excited to offer a poster session, and submission is still open. In addition, poster
presentations from previous conferences as well as interesting case reports are welcome.

MRD webinar

Thank you to the panelists of our MRD webinar 2023-10-10. For a recording of the webinar use this link.

Nordic AML webinar

Thank you to all participants for taking part in the Nordic AML webinar 2023-11-08. For a recording of the webinar use this link.

Myeloid Neoplasia StemCellTransplant (MNSCT) Nordic workshop

We are thrilled to invite you all to the first MNSCT workshop. The program is planned by a scientific committee from the Swedish-Norwegian BMT-group and the Swedish AML-group. The overarching aim of this meeting is to stimulate discussions around topics within the Nordic community. Please register for this event using this link (deadline 2023-10-27). Click here for more […]

Webinar – Immunotherapy: a new perspective for AML maintenance treatment?

Agenda AML patients not candidates to allotransplant: relapse risk and therapeutics (Pr Bjorn Gjertsen) Immunotherapy with Histamine dihydrochloride in association with low-dose interleukin-2 (HDC/IL-2) for relapse prevention (Pr Kristoffer Hellstrand) Conceivable indications of HDC/IL-2 for post-remission in AML? (Pr Bjorn Gjertsen, Dr Martin Jädersten, Dr Lovisa Wennström) For more info, click here. For registration, click […]

NAMLG TWG Meeting – I – 24-01-2024 15:30-16:30 CET

Link and passcode for Teams meeting sent separately. Agenda: Update on potential LD-VenEx amendment trial comparing poDEC/LD-VenEx vs. AZA/LD-VenEx (5 min + 10 min discussion). NAMLG – platform trial structure concept (5 min): Infrastructure with standing collaboration contracts (clinical trial agreement – CTA) and data processing agreements (DPAs) applicable for all types of trials. This […]

Early Response Evaluation by Single-Cell Signaling Profiling in AML

Webinar to be held January 25 at 16:00 This is in Standard Biotools’ (former Fluidigm) Scientist in the Spotlight series. More info and registration on this link. Hear about: Insights into AML response: Discover the initial signaling response to standard induction chemotherapy in a cohort of 32 AML patients.   Predicting 5-year survival: Learn about the significant predictors of patient […]